Market Overview:
The global 3D bioprinting for life science R&D market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for organ transplants, rising prevalence of chronic diseases, and technological advancements in 3D printing technology. In terms of type, the magnetic 3D bioprinting segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to its ability to print complex structures with high precision and accuracy. By application, the clinical segment is expected to hold a dominant share in terms of revenue in 2018 and is projected to maintain its dominance throughout the forecast period.
Product Definition:
3D bioprinting is the process of creating three-dimensional structures using cells. 3D printing is a technology that has been around for many years, and has been used to create items such as prosthetic body parts and eyeglasses. With the help of 3D bioprinters, scientists can now print living tissues and organs. This technology could potentially be used to create replacement tissues and organs for people who need them, which could revolutionize the field of medicine.
Magnetic 3D Bioprinting:
Magnetic 3D bioprinting is a technique that uses magnetic fields to guide cells and tissues as they are built layer by layer in a computer-aided design. This technology has been used for many years in the field of Additive Manufacturing (AM), but it has only recently been commercialized.
Laser-Assisted Bioprinting:
Laser-assisted bioprinting is a technique that uses laser for the deposition of cells, tissues and other biological materials on any surface. This technology has gained significant traction in recent years owing to its wide range of applications such as rapid prototyping, tissue engineering and drug screening. The process involves high precision software control systems along with advanced equipment which helps in producing accurate prototypes with enhanced features.
Application Insights:
The clinical application segment accounted for the largest revenue share in 2017 owing to increasing adoption of 3D bioprinting techniques for tissue engineering and regenerative medicine. The ability of 3D bioprinting to fabricate tissues with complex structural properties, cellular dynamics, and physiological functions makes it suitable for clinical applications.
In recent years, several research groups have reported the use of 3D bioprinting in stem cell research. The ability to culture cells using micro-engineering techniques enables researchers to study the developmental stages of a cell before its implantation into a patient¢â‚¬â„¢s body. This technique also allows them to test different conditions on single cells before trying them out on an entire organism which is expected to boost R&D productivity over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and well-established research infrastructure. The region is expected to maintain its dominance throughout the forecast period due to increasing government funding for biomedical research, technological advancements, and high healthcare expenditure.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to an increase in healthcare spending by governments as well as private organizations in order for improving public health systems. Moreover, growing investments by companies for developing novel products through bioprinting technology will drive regional growth during the forecast period.
Growth Factors:
- Advances in 3D printing technology that can produce more accurate and consistent results, especially for complex structures.
- Increasing demand for tissue engineering and regenerative medicine therapies.
- Growing interest in using 3D bioprinting to create personalized medicines.
- Rising number of collaborations between life science companies and 3D printing startups to develop new applications for the technology.
- decreasing costs of 3D printers and bioinks, making them more accessible to researchers
Scope Of The Report
Report Attributes
Report Details
Report Title
3D Bioprinting for Life Science R&D Market Research Report
By Type
Magnetic 3D Bioprinting, Laser-Assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting
By Application
Clinical, Research
By Companies
EnvisionTEC, Regenovo, Organovo, 3D Systems, 3D Biotek, Advanced Biomatrix, Digilab, Nano3D Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global 3D Bioprinting for Life Science R&D Market Report Segments:
The global 3D Bioprinting for Life Science R&D market is segmented on the basis of:
Types
Magnetic 3D Bioprinting, Laser-Assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EnvisionTEC
- Regenovo
- Organovo
- 3D Systems
- 3D Biotek
- Advanced Biomatrix
- Digilab
- Nano3D Biosciences
Highlights of The 3D Bioprinting for Life Science R&D Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Magnetic 3D Bioprinting
- Laser-Assisted Bioprinting
- Inkjet 3D Bioprinting
- Microextrusion 3D Bioprinting
- By Application:
- Clinical
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3D Bioprinting for Life Science R&D Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
3D Bioprinting is a process that uses digital models to create three-dimensional objects from biological materials. This technology can be used for life science research and development, as it allows scientists to create customized 3D structures of cells and tissues using biodegradable materials.
Some of the major players in the 3d bioprinting for life science r&d market are EnvisionTEC, Regenovo, Organovo, 3D Systems, 3D Biotek, Advanced Biomatrix, Digilab, Nano3D Biosciences.
The 3d bioprinting for life science r&d market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 3D Bioprinting for Life Science R&D Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 3D Bioprinting for Life Science R&D Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 3D Bioprinting for Life Science R&D Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 3D Bioprinting for Life Science R&D Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 3D Bioprinting for Life Science R&D Market Size & Forecast, 2018-2028
4.5.1 3D Bioprinting for Life Science R&D Market Size and Y-o-Y Growth
4.5.2 3D Bioprinting for Life Science R&D Market Absolute $ Opportunity
Chapter 5 Global 3D Bioprinting for Life Science R&D Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 3D Bioprinting for Life Science R&D Market Size Forecast by Type
5.2.1 Magnetic 3D Bioprinting
5.2.2 Laser-Assisted Bioprinting
5.2.3 Inkjet 3D Bioprinting
5.2.4 Microextrusion 3D Bioprinting
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global 3D Bioprinting for Life Science R&D Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
6.2.1 Clinical
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 3D Bioprinting for Life Science R&D Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 3D Bioprinting for Life Science R&D Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America 3D Bioprinting for Life Science R&D Analysis and Forecast
9.1 Introduction
9.2 North America 3D Bioprinting for Life Science R&D Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America 3D Bioprinting for Life Science R&D Market Size Forecast by Type
9.6.1 Magnetic 3D Bioprinting
9.6.2 Laser-Assisted Bioprinting
9.6.3 Inkjet 3D Bioprinting
9.6.4 Microextrusion 3D Bioprinting
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
9.10.1 Clinical
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe 3D Bioprinting for Life Science R&D Analysis and Forecast
10.1 Introduction
10.2 Europe 3D Bioprinting for Life Science R&D Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe 3D Bioprinting for Life Science R&D Market Size Forecast by Type
10.6.1 Magnetic 3D Bioprinting
10.6.2 Laser-Assisted Bioprinting
10.6.3 Inkjet 3D Bioprinting
10.6.4 Microextrusion 3D Bioprinting
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
10.10.1 Clinical
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific 3D Bioprinting for Life Science R&D Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific 3D Bioprinting for Life Science R&D Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific 3D Bioprinting for Life Science R&D Market Size Forecast by Type
11.6.1 Magnetic 3D Bioprinting
11.6.2 Laser-Assisted Bioprinting
11.6.3 Inkjet 3D Bioprinting
11.6.4 Microextrusion 3D Bioprinting
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
11.10.1 Clinical
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America 3D Bioprinting for Life Science R&D Analysis and Forecast
12.1 Introduction
12.2 Latin America 3D Bioprinting for Life Science R&D Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America 3D Bioprinting for Life Science R&D Market Size Forecast by Type
12.6.1 Magnetic 3D Bioprinting
12.6.2 Laser-Assisted Bioprinting
12.6.3 Inkjet 3D Bioprinting
12.6.4 Microextrusion 3D Bioprinting
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
12.10.1 Clinical
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) 3D Bioprinting for Life Science R&D Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) 3D Bioprinting for Life Science R&D Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) 3D Bioprinting for Life Science R&D Market Size Forecast by Type
13.6.1 Magnetic 3D Bioprinting
13.6.2 Laser-Assisted Bioprinting
13.6.3 Inkjet 3D Bioprinting
13.6.4 Microextrusion 3D Bioprinting
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) 3D Bioprinting for Life Science R&D Market Size Forecast by Applications
13.10.1 Clinical
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 3D Bioprinting for Life Science R&D Market: Competitive Dashboard
14.2 Global 3D Bioprinting for Life Science R&D Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EnvisionTEC
14.3.2 Regenovo
14.3.3 Organovo
14.3.4 3D Systems
14.3.5 3D Biotek
14.3.6 Advanced Biomatrix
14.3.7 Digilab
14.3.8 Nano3D Biosciences
